|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 04804250.1 (espacenet) (Federated) (European Patent Register), 20041223 | | Patent/reg. no. and date | DK/EP 1696905, 20080319 | | Publication date | 20060906 | | Priority no. and date | DE 10361258, 20031224 | | EP pub. no. and date |
EP 1696905 20060906 | | Effective date | | | Applicant/owner | UCB Pharma GmbH, Alfred-Nobel-Strasse 10
40789 Monheim, DE | | Applicant ref. no. | p80802002DK00E | | Inventor | DRESSEN, Frank, Am Heidegraben 9
52391 Vettweiss, DE,
SCHELLER, Dieter, Bettikumer Dorfstr. 13
41470 Neuss, DE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/381 (2006.01) , A61P 25/16 (2006.01) | | Title | Substituerede 2-aminotetraliner til forebyggende behandling af Morbus Parkinson | | Int. application no. | EP2004014656 | | Int. publication no. | WO2005063238 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
